Showing results (91-100 of 195) with videos related to

Sort By:
Pageof 20
Microbiology Spectrum|April 8, 2025
Improved isolation and PCR detection of <i>Phytophthora agathidicida</i> oospores from soilsJade T T Palmer, Jochem N A Vink, Leticia M Castro, et al.
Viruses|March 30, 2023
Efficient CRISPR-Cas13d-Based Antiviral Strategy to Combat SARS-CoV-2Mouraya Hussein, Zaria Andrade Dos Ramos, Monique A Vink, et al.
Atherosclerosis|June 28, 2001
The adventitia of atherosclerotic coronary arteries frequently contains Chlamydia pneumoniaeA Vink, G Pasterkamp, M Poppen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 5, 2006
The integration profile of EIAV-based vectorsCaroline V Hacker, Conrad A Vink, Theresa W Wardell, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 16, 2015
REVascularization with paclitaxEL-coated balloon angioplasty versus drug-eluting stenting in acute myocardial infarcTION-A randomized controlled trial: Rationale and design of the REVELATION trialNicola S Vos, Rene J van der Schaaf, Giovanni Amoroso, et al.
Seminars in Cardiothoracic and Vascular Anesthesia|May 19, 2010
New predictors of adverse cardiovascular events following vascular surgeryG W van Lammeren, J P P M de Vries, A Vink, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 31, 2008
Two year follow-up after primary PCI with a paclitaxel-eluting stent versus a bare-metal stent for acute ST-elevation myocardial infarction (the PASSION trial): a follow-up studyMaurits T Dirksen, Maarten A Vink, Maarten J Suttorp, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 22, 2008
Carotid atherosclerotic plaques stabilize after stroke: insights into the natural process of atherosclerotic plaque stabilizationW Peeters, W E Hellings, D P V de Kleijn, et al.
Science (New York, N.Y.)|August 27, 2021
The gRAMP CRISPR-Cas effector is an RNA endonuclease complexed with a caspase-like peptidaseSam P B van Beljouw, Anna C Haagsma, Alicia Rodríguez-Molina, et al.
Pageof 20